|
Multiple sclerosis
Citations 411-420 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region
- B. A. de Jong, T. W.J. Huizinga, E. Zanelli, M. J. Giphart, E. L.E.M. Bollen, B. M.J. Uitdehaag, C. H. Polman, and R. G.J. Westendorp
Neurology 2002; 59: 549-555.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
- L. M. Villar, J. Masjuan, P. González-Porqué, J. Plaza, M. C. Sádaba, E. Roldán, A. Bootello, and J. C. Alvarez-Cermeño
Neurology 2002; 59: 555-559.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Interferon beta but not glatiramer acetate therapy aggravates headaches in MS
- W. Pöllmann, L. -P. Erasmus, W. Feneberg, F. Then Bergh, and A. Straube
Neurology 2002; 59: 636-639.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer’s disease
- A. Delacourte, N. Sergeant, D. Champain, A. Wattez, C.-A. Maurage, F. Lebert, F. Pasquier, and J.-P. David
Neurology 2002; 59: 398-407.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS
- A. Traboulsee, J. Dehmeshki, P. A. Brex, C. M. Dalton, D. Chard, G. J. Barker, G. T. Plant, and D. H. Miller
Neurology 2002; 59: 126-128.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Neutralizing antibodies reduce MxA protein induction in interferon- beta-1a-treated MS patients
- A.-M. Vallittu, M. Halminen, J. Peltoniemi, J. Ilonen, I. Julkunen, A. Salmi, J.-P. Erälinna, and the Finnish Beta-Interferon Study Group
Neurology 2002; 58: 1786-1790.
[Abstract]
[Full text]
[PDF]
- NEUROIMAGES
Painful third nerve palsy in MS
- P.I. Bentley, T. Kimber, and A.H.V. Schapira
Neurology 2002; 58: 1532.
[Full text]
[PDF]
- EDITORIALS
Cannabinoids in MS: Potentially useful but not just yet!
- Alan J. Thompson and David Baker
Neurology 2002; 58: 1323-1324.
[Full text]
[PDF]
- ARTICLES
Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit
- E. Silber, Y. K. Semra, N.A. Gregson, and M. K. Sharief
Neurology 2002; 58: 1372-1381.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
- J. Killestein, E. L.J. Hoogervorst, M. Reif, N. F. Kalkers, A. C. van Loenen, P. G.M. Staats, R. W. Gorter, B. M.J. Uitdehaag, and C. H. Polman
Neurology 2002; 58: 1404-1407.
[Abstract]
[Full text]
[PDF]
|
|
